Head to Head Survey: WORK Medical Technology Group (NASDAQ:WOK) vs. Integra LifeSciences (NASDAQ:IART)

Integra LifeSciences (NASDAQ:IART) and WORK Medical Technology Group (NASDAQ:WOK) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their institutional ownership, dividends, earnings, risk, analyst recommendations, profitability and valuation.

Insider and Institutional Ownership

84.8% of Integra LifeSciences shares are held by institutional investors. 3.5% of Integra LifeSciences shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Earnings & Valuation

This table compares Integra LifeSciences and WORK Medical Technology Group”s revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Integra LifeSciences	$1.64 billion	0.53	-$516.47 million	($6.73)	-1.66
WORK Medical Technology Group	$9.81 million	0.00	-$1.07 million	N/A	N/A

WORK Medical Technology Group has lower revenue, but higher earnings than Integra LifeSciences.

Profitability

This table compares Integra LifeSciences and WORK Medical Technology Group’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Integra LifeSciences	-31.58%	14.76%	4.58%
WORK Medical Technology Group	N/A	N/A	N/A

Analyst Ratings

This is a breakdown of current ratings and price targets for Integra LifeSciences and WORK Medical Technology Group, as provided by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Integra LifeSciences	3	3	1	0	1.71
WORK Medical Technology Group	1	0	0	0	1.00

Integra LifeSciences presently has a consensus target price of $14.20, suggesting a potential upside of 27.47%. Given Integra LifeSciences’ stronger consensus rating and higher possible upside, analysts plainly believe Integra LifeSciences is more favorable than WORK Medical Technology Group.

Risk & Volatility

Integra LifeSciences has a beta of 1.06, meaning that its stock price is 6% more volatile than the S&P 500. Comparatively, WORK Medical Technology Group has a beta of 2.68, meaning that its stock price is 168% more volatile than the S&P 500.

Summary

Integra LifeSciences beats WORK Medical Technology Group on 9 of the 12 factors compared between the two stocks.

About Integra LifeSciences

Integra LifeSciences Holdings Corporation manufactures and sells surgical instruments, neurosurgical products, and wound care products for use in neurosurgery, neurocritical care, and otolaryngology. It operates in two segments, Codman Specialty Surgical and Tissue Technologies. The company offers neurosurgery and neuro critical care products, including tissue ablation equipment, dural repair products, cerebral spinal fluid management devices, intracranial monitoring equipment, and cranial stabilization equipment; and surgical headlamps and instrumentation, as well as after-market services. It also sells instrument patterns, and surgical and lighting products to hospitals and surgery centers, as well as dental, podiatry, and veterinary offices. In addition, the company provides regenerative technology products for the treatment of acute wounds; and surgical tissue repair products for hernia, tendon, peripheral nerve repair and protection. Further, it offers skin and wound repair, plastics and surgical reconstruction products, bone grafts, and nerve and tendon repair products. The company offers its products directly through various sales forces and other distribution channels to the hospitals, integrated health networks, group purchasing organizations, clinicians, surgery centers, and health care providers in the United States, Europe, Asia Pacific, and internationally. Integra LifeSciences Holdings Corporation was incorporated in 1989 and is headquartered in Princeton, New Jersey.

About WORK Medical Technology Group

WORK Medical Technology Group Ltd. engages in developing health instruments. It manufactures and sells medical devices, including endotracheal tubes, laryngeal mask airways, heat and moisture exchanging filters, disposable breathing circuits, nebulizer kits, and yankauer suction sets. The company was founded on March 1, 2022 and is headquartered in Hangzhou, China.